AGHEMO, Alessio Michele Goffredo

AGHEMO, Alessio Michele Goffredo  

Dipartimento Scienze Biomediche  

Mostra records
Risultati 1 - 20 di 286 (tempo di esecuzione: 0.035 secondi).
Titolo Data di pubblicazione Autore(i) File
12 weeks ombitasvir/paritaprevir-ritonavir plus ribavirin achieve high SVR rates in HCV-4 patients with advanced fibrosis 1-gen-2018 Degasperi, E; Aghemo, A; Paolucci, S; D'Ambrosio, R; Borghi, M; Perbellini, R; Novazzi, F; De Nicola, S; Lunghi, G; Baldanti, F; Lampertico, P
A 13-day, interferon-free regimen for chronic hepatitis C genotype 1 patients: between fear and hope. 1-gen-2011 Aghemo, A; Colombo, M.
An a priori prediction model of response to peginterferon plus ribavirin dual therapy in naive patients with genotype 1 chronic hepatitis C 1-gen-2014 Andriulli, A; Nardi, A; Di Marco, V; Ippolito, Am; Gavrila, C; Aghemo, A; Di Paolo, D; Squadrito, G; Grassi, E; Calvaruso, V; Valvano, Mr; Brancaccio, G; Craxi, A; Angelico, M
A rapid point-of-care test for the diagnosis of HCV infection: tipping the balance to screening extension beyond high risk populations? 1-gen-2011 Aghemo, A; Colombo, M.
A Review of the Treatment of Chronic Hepatitis C Virus Infection in Cirrhosis 1-gen-2010 Vezali, E; Aghemo, A; Colombo, M
Accelerating the elimination of viral hepatitis: a Lancet Gastroenterology & Hepatology Commission 1-gen-2019 Cooke, Gs; Andrieux-Meyer, I; Applegate, Tl; Atun, R; Burry, Jr; Cheinquer, H; Dusheiko, G; Feld, Jj; Gore, C; Griswold, Mg; Hamid, S; Hellard, Me; Hou, Jl; Howell, J; Jia, Jd; Kravchenko, N; Lazarus, Jv; Lemoine, M; Lesi, Oa; Maistat, L; Mcmahon, Bj; Razavi, H; Roberts, Tr; Simmons, B; Sonderup, Mw; Spearman, Cw; Taylor, Be; Thomas, Dl; Waked, I; Ward, Jw; Wiktor, Sz; Abdo, A; Aggarwal, R; Aghemo, A; Al-Judaibi, B; Al Mahtab, M; Altaf, A; Ameen, Z; Asselah, T; Baatarkkhuu, O; Barber, E; Barnes, E; Boulet, P; Burrows, L; Butsashvili, M; Chan, E; Chow, C; Cowie, B; Cunningham, C; de Araujo, A; Diap, G; Dore, G; Doyle, J; Elsayed, M; Fajardo, E; Gane, E; Getehun, A; Goldberg, D; Got, T; Hickman, M; Hill, A; Howell, J; Hutchinson, S; Jones, C; Kamili, S; Khan, A; Lee, A; Lee, Ty; Malani, J; Morris, Tm; Nayagam, S; Njouom, R; Ocama, P; Pedrana, A; Peeling, R; Reddy, A; Roberts, T; Sacks, J; Sarin, S; Shimakawa, Y; Silva, M; Skala, P; Taylor-Robinson, S; Thompson, A; Thursz, M; Tonganibeia, A; Wallace, J; Ward, J; Wolff, F; Vickerman, P; Yau, J
Acute allograft rejection following interferon therapy for hepatitis C in recipients who have returned to dialysis after kidney transplant failure: Case study 1-gen-2014 Fabrizi, F; D'Ambrosio, R; Pallotti, F; Berardinelli, L; Messa, P; Martin, P; Aghemo, A
Acute tubular necrosis following interferon-based therapy for hepatitis C : case study with literature review 1-gen-2014 Fabrizi, F.; Aghemo, A.; Fogazzi, G. B.; Moroni, G.; Passerini, P.; D'Ambrosio, R.; Messa, P.
Adherence to pan-genotypic glecaprevir/pibrentasvir and efficacy in HCV-infected patients: A pooled analysis of clinical trials 1-gen-2020 Brown, A; Welzel, Tm; Conway, B; Negro, F; Brau, N; Grebely, J; Puoti, M; Aghemo, A; Kleine, H; Pugatch, D; Mensa, Fj; Chen, Yzj; Lei, Y; Lawitz, E; Asselah, T
Age Might Confound the Impact of the Transmembrane 6 Superfamily Member 2 E167K Polymorphism on Hepatic Fibrosis in Hepatitis C Virus-Infected Patients REPLY 1-gen-2016 Romeo, S.; Aghemo, A.; Berg, T.; Stickel, F.; Valenti, L.
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing Cholangitis 1-gen-2020 Roda, G; Lleo de nalda, A; Danese, S; Aghemo, A
Allelic inhibition of displacement activity: A simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms 1-gen-2013 Galmozzi, E; Facchetti, F; Degasperi, E; Aghemo, A; Lampertico, P
Alpha-fetoprotein screening in patients with hepatitis C-induced cirrhosis who achieved a sustained virologic response in the direct-acting antiviral agents era 1-gen-2018 Spadaccini, M; Lleo, A; Ceriani, R; Covini, G; Rimassa, L; Torzilli, G; Di Tommaso, L; Aghemo, A
Anemia during peginterferon-ribavirin therapy results from both increased suppression of erythroid differentiation and haemolysis 1-gen-2008 Aghemo, A.; Ronzoni, L.; Rumi, M.; Monico, S.; Colancecco, A.; Grillo, P.; Viganò, M.; Cappellini, M. D.; Colombo, M.
Anti-TNF drugs in patients with hepatitis B or C virus infection: safety and clinical management 1-gen-2012 Vigano, M; Degasperi, E; Aghemo, A; Lampertico, P; Colombo, M
Assessing long-term treatment efficacy in chronic hepatitis B and C : Between evidence and common sense 1-gen-2012 Aghemo, A.; Lampertico, P.; Colombo, M.
Assessing safety and efficacy of sofosbuvir for the treatment of hepatitis C 1-gen-2015 D'Ambrosio, R; Aghemo, A; Colombo, M
The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent 1-gen-2014 D'Ambrosio, R.; Aghemo, A.; De Francesco, R.; Rumi, M. G.; Galmozzi, E.; De Nicola, S.; Cheroni, C.; Clark, P. J.; Ronchi, G.; Lampertico, P.; Colombo, M.
Autoimmune Hepatitis During Ledipasvir/Sofosbuvir Treatment of Hepatitis C: A Case Report 1-gen-2018 Covini, G; Bredi, E; Badalamenti, S; Roncalli, M; Aghemo, A; Colombo, M
Bridging all oral DAA therapy from wait time to post-liver transplant to improve HCV eradication? 1-gen-2015 Donato, M. F.; Monico, S.; Malinverno, F.; Aghemo, A.; Maggioni, M.; Reggiani, P.; Colombo, M.